| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/20/2007 | US7179807 5-substituted-2-arylpyrazines |
| 02/20/2007 | US7179805 Microbiocides; bactericides |
| 02/20/2007 | US7179804 Tachykinin receptor antagonists |
| 02/20/2007 | US7179803 Method of modulating ion channel functional activity |
| 02/20/2007 | US7179802 reducing the risk of developing a condition selected from the group consisting of hypercholesterolemia, atherosclerosis, low HDL levels, high LDL levels, hyperlipidemia, hypertriglyceridemia and dyslipidemia |
| 02/20/2007 | US7179801 Cephem compounds |
| 02/20/2007 | US7179800 Cannabinoids |
| 02/20/2007 | US7179799 (3) and (6) substituted estrogenic compounds |
| 02/20/2007 | US7179798 Comprises progesterone dilutions; for bone and/or joint pain |
| 02/20/2007 | US7179795 Nucleic acids encoding chimeric proteins comprising BMP-2 and a proteinase inhibitor |
| 02/20/2007 | US7179794 Antibiotics; bactericides |
| 02/20/2007 | US7179792 Combination product of a 1,4-benzothiepine 1,1-dioxide compound with at least one other active ingredient and the use of the product |
| 02/20/2007 | US7179791 Inhibiting GS-FDH to modulate NO bioactivity |
| 02/20/2007 | US7179771 Composition |
| 02/20/2007 | US7179647 For introducing DNA into organisms which produce large amounts of oils and, in particular, oils with a high content of unsaturated fatty acids |
| 02/20/2007 | US7179646 Useful for obtaining tumour-selective gene expression in tumours having a mutated beta -catenin pathway; used to express genes encoding therapeutic proteins in colorectal cancer cells |
| 02/20/2007 | US7179645 Hybrid polypeptide; induce immunology response, antiallergens; major histocompatibility complex; vaccine |
| 02/20/2007 | US7179632 Process for the production of allicin |
| 02/20/2007 | US7179588 Assay for the detection of paclitaxel resistant cells in human tumors |
| 02/20/2007 | US7179495 Hyperforin as cytostatic agent and hyperforin ointment or cream as application form |
| 02/20/2007 | US7179493 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 02/20/2007 | US7179491 Contacting marine oil with an effective amount of a silica under a vacuum;contacting the oil with an effective amount of a bleaching clay;separating the silica from the oil; and separating the clay from the oil |
| 02/20/2007 | US7179489 Mixing micronised formoterol its salt or solvate with a pre-micronised carrier/diluent at low energy, agglomerating and spheronisation or adding a coarse carrier/diluent; treating respiratory system disorders |
| 02/20/2007 | US7179483 Compositions and methods for transdermal oxybutynin therapy |
| 02/20/2007 | US7179482 Implant device with a retinoid for improved biocompatibility |
| 02/20/2007 | US7179481 Increasing growth of epithelial cells in the female reproductive tract by administering to the vaginal cavity a retinoid or a carotenoid; treating vaginal dryness for example |
| 02/20/2007 | US7179476 Medical composition for external use for dermatosis |
| 02/20/2007 | US7179457 Modified to include heterologous insertion downstream of its replicase open reading frames; insertion preferably comprises one or more protein-coding regions ideal for virus-like particles packaging |
| 02/20/2007 | CA2455050C Crystals including a malic acid salt of n-[2-(diethylamino) ethyl]-5-[(5-fluoro-2-oxo-3h-indole-3-ylidene) methyl]-2, 4-dimethyl-1h-pyrrole-3-carboxamide, processes for its preparation and compositions thereof |
| 02/20/2007 | CA2422374C Purine derivatives |
| 02/20/2007 | CA2407429C Composition for the regulation of the human immune system and the prevention and treatment of diseases thereof |
| 02/20/2007 | CA2375225C Mutual salt of amlodipine and atorvastatin |
| 02/20/2007 | CA2371174C Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors |
| 02/20/2007 | CA2365078C Dietary compositions and methods |
| 02/20/2007 | CA2344574C Thyroid receptor ligands |
| 02/20/2007 | CA2335520C Adenosine derivatives |
| 02/20/2007 | CA2325776C Novel analogue compounds of camptothecin, process for preparing them and pharmaceutical compositions containing them |
| 02/20/2007 | CA2289979C Methods of modulating immune coagulation |
| 02/20/2007 | CA2284058C Diffusional implantable delivery system |
| 02/20/2007 | CA2283929C Method for treating headache pain with topical local anesthetic compositions |
| 02/20/2007 | CA2270565C Progesterone for treating or reducing ischemia |
| 02/20/2007 | CA2270551C Washing disinfectant for hygienic and surgical hand disinfection |
| 02/20/2007 | CA2263561C Thienopyrimidines |
| 02/20/2007 | CA2251086C Glycopeptide compounds |
| 02/20/2007 | CA2250117C Method and composition for cleansing wounds with minimal cytotoxicity for minimal scarring |
| 02/20/2007 | CA2223908C Use of squalamine for the manufacture of a medicament for inhibiting nhe |
| 02/20/2007 | CA2218872C Preparation and use of sulfated oligosaccharides |
| 02/20/2007 | CA2198389C Triphenylethylenes for the prevention and treatment of osteoporosis |
| 02/20/2007 | CA2188567C Wet granulation formulation for bisphosphonic acids |
| 02/20/2007 | CA2186784C The use of carboxylic acid derivatives as drugs |
| 02/20/2007 | CA2180156C Self-assembled taxo-diperpenoid nanostructures |
| 02/20/2007 | CA2151438C Thermostable trehalose-releasing enzyme, and its preparation and uses |
| 02/20/2007 | CA2128044C Pharmaceutical compositions comprising a glucosidase and/or amylase inhibitor, and a lipase inhibitor |
| 02/20/2007 | CA2119745C Nonpeptidyl integrin inhibitors having specificity for gpiibiiia receptor |
| 02/19/2007 | CA2516745A1 Botulinum toxin in treatment of clubfoot relapse |
| 02/15/2007 | WO2007019554A2 Polysaccharides for delivery of active agents |
| 02/15/2007 | WO2007019550A2 Composition and method for use in cartilage affecting conditions |
| 02/15/2007 | WO2007019549A2 Composition and method for use in cartilage affecting conditions |
| 02/15/2007 | WO2007019540A2 Controlled release alpha-lipoic acid formulation with an inositol compound |
| 02/15/2007 | WO2007019526A2 Compositions and methods for controlling glucose and lipid uptake from foods |
| 02/15/2007 | WO2007019463A2 Methods of delivering therapeutics to the brain |
| 02/15/2007 | WO2007019448A2 Nitric oxide enhancing angiotensin ii antagonist compounds, compositions and methods of use |
| 02/15/2007 | WO2007019439A2 Block copolymer compositions and uses thereof |
| 02/15/2007 | WO2007019417A1 Oxazolopyridine derivatives as sirtuin modulators |
| 02/15/2007 | WO2007019416A1 Benzimidazole derivatives as sirtuin modulators |
| 02/15/2007 | WO2007019378A2 Method of treating neurological disorders |
| 02/15/2007 | WO2007019373A2 Novel formulations comprising fenofibrate and a statin, and related methods of treatment |
| 02/15/2007 | WO2007019346A1 Benzothiazoles and thiazolopyridines as sirtuin modulators |
| 02/15/2007 | WO2007019345A1 Imidazopyridine derivatives as sirtuin modulating agents |
| 02/15/2007 | WO2007019344A1 Imidazo [2,1-b] thiazole derivatives as sirtuin modulating compounds |
| 02/15/2007 | WO2007019308A2 Illudin analogs useful as anticancer agents |
| 02/15/2007 | WO2007019255A2 Salts of vildagliptin |
| 02/15/2007 | WO2007019251A2 Sphingosine kinase inhibitors and methods of their use |
| 02/15/2007 | WO2007019234A2 Aminoethane sulfonamide orexin receptor antagonists |
| 02/15/2007 | WO2007019224A2 Formulations and methods for enhancing the transdermal penetration of a drug |
| 02/15/2007 | WO2007019221A2 Pharmaceutical compositions of silicon-containing substituted adenosine nucleoside amide analogs |
| 02/15/2007 | WO2007019191A2 Thiazolopyrimidine kinase inhibitors |
| 02/15/2007 | WO2007019184A2 Oral suspension of prednisolone acetate |
| 02/15/2007 | WO2007019153A2 Methods for treating hypertension |
| 02/15/2007 | WO2007019131A2 Use of lipid conjugates in cystic fibrosis and applications thereof |
| 02/15/2007 | WO2007019130A2 Hiv integrase inhibitors |
| 02/15/2007 | WO2007019116A1 Use of hdac inhibitors for the treatment of myeloma |
| 02/15/2007 | WO2007019111A2 Cyclic ketal beta-secretase inhibitors for the treatment of alzheimer's disease |
| 02/15/2007 | WO2007019101A2 Hiv integrase inhibitors |
| 02/15/2007 | WO2007019100A2 Hiv integrase inhibitors |
| 02/15/2007 | WO2007019098A2 Hiv integrase inhibitors |
| 02/15/2007 | WO2007019083A1 Pyrimidine compounds as serotonin receptor modulators |
| 02/15/2007 | WO2007019080A2 Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease |
| 02/15/2007 | WO2007019078A2 Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease |
| 02/15/2007 | WO2007019065A2 Adjuvant chemotherapy for anaplastic gliomas |
| 02/15/2007 | WO2007019058A1 Tocopheryl polyethylene glycol succinate powder and process for preparing same |
| 02/15/2007 | WO2007018818A1 A pyridin quinolin substituted pyrrolo [1,2-b] pyrazole monohydrate as tgf-beta inhibitor |
| 02/15/2007 | WO2007018738A2 Fused bicycloheterocycle substituted quinuclidine derivatives |
| 02/15/2007 | WO2007018687A1 Compositions and methods for treatment and prevention of hyperuricemia related health consequences |
| 02/15/2007 | WO2007018660A2 Gabaergic imidazobenzodiazepine derivatives to treat memory deficits |
| 02/15/2007 | WO2007018640A1 New capped pyrazinoylguanidine sodium channel blockers |
| 02/15/2007 | WO2007018622A2 Vaginal treatment composition |
| 02/15/2007 | WO2007018588A1 Stable pharmaceutical composition comprising linezolid form iv |
| 02/15/2007 | WO2007018546A1 Modulation of cell fates and activities by phthalazinediones |
| 02/15/2007 | WO2007018514A1 Novel m3 muscarinic acetylcholine receptor antagonists |